Trinity shares soar over green light for HIV test

SHARES in Trinity Biotech soared by nearly 15% yesterday after it received approval from the US drug regulator to sell a new test for HIV.

Trinity is already selling the Uni-Gold product in Africa and Asia and the approval by the US Food & Drug Administration is a major boost.

The test, which gives the result of a blood test in 10 minutes, was approved for the detection of antibodies to HIV in human serum, plasma, venous and finger stick whole blood.